Postponed absorption of dabigatran in a patient with paralytic ileus – difficulties in decision making on reversal agent (idarucizumab) use
European Journal of Translational and Clinical Medicine · 2019
DOI: 10.31373/ejtcm/109298 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Translational and Clinical Medicine, 2019. Verfasst von Anna Tomaszuk-Kazberuk und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tomaszuk-Kazberuk, A., Paulina, L., Elzbieta, M., & Bozena, S. (2019). Postponed absorption of dabigatran in a patient with paralytic ileus – difficulties in decision making on reversal agent (idarucizumab) use. European Journal of Translational and Clinical Medicine. https://doi.org/10.31373/ejtcm/109298
Vancouver
Tomaszuk-Kazberuk A, Paulina L, Elzbieta M, Bozena S. Postponed absorption of dabigatran in a patient with paralytic ileus – difficulties in decision making on reversal agent (idarucizumab) use. European Journal of Translational and Clinical Medicine. 2019. doi:10.31373/ejtcm/109298
BibTeX
@article{TomaszukKazberuk2019,
author = {Tomaszuk-Kazberuk, Anna and Paulina, Lopatowska and Elzbieta, Mlodawska and Bozena, Sobkowicz},
title = {Postponed absorption of dabigatran in a patient with paralytic ileus – difficulties in decision making on reversal agent (idarucizumab) use},
journal = {European Journal of Translational and Clinical Medicine},
year = {2019},
doi = {10.31373/ejtcm/109298}
}
EUVIMED